These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 11256231)

  • 1. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.
    Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
    Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):609-13. PubMed ID: 11256231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z
    Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
    Zhao Q; Tang XC
    Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
    Nordberg A; Darreh-Shori T; Peskind E; Soininen H; Mousavi M; Eagle G; Lane R
    Curr Alzheimer Res; 2009 Feb; 6(1):4-14. PubMed ID: 19199870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
    Jann MW; Shirley KL; Small GW
    Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
    Liston DR; Nielsen JA; Villalobos A; Chapin D; Jones SB; Hubbard ST; Shalaby IA; Ramirez A; Nason D; White WF
    Eur J Pharmacol; 2004 Feb; 486(1):9-17. PubMed ID: 14751402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.
    Amici S; Lanari A; Romani R; Antognelli C; Gallai V; Parnetti L
    Mech Ageing Dev; 2001 Nov; 122(16):2057-62. PubMed ID: 11589922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
    Zurek E; Szymański P; Mikiciuk-Olasik E
    Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
    Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
    Eur J Pharmacol; 2001 Mar; 415(2-3):157-64. PubMed ID: 11274994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
    Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
    Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats.
    Kosasa T; Kuriya Y; Yamanishi Y
    Jpn J Pharmacol; 1999 Oct; 81(2):216-22. PubMed ID: 10591480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
    Dronfield S; Egan K; Marsden CA; Green AR
    J Psychopharmacol; 2000; 14(3):275-9. PubMed ID: 11106308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
    Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
    Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
    Naik RS; Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
    J Pharm Pharm Sci; 2009; 12(1):79-85. PubMed ID: 19470293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor.
    Sugimoto H; Ogura H; Arai Y; Limura Y; Yamanishi Y
    Jpn J Pharmacol; 2002 May; 89(1):7-20. PubMed ID: 12083745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
    Wang N; Jia W; Wang J; Yang Z; Liu Y; Huang D; Mei X; Xiong X; Shi J; Tang Y; Chen G; Di D; Hou Y; Liu Y
    Bioorg Chem; 2024 Feb; 143():107010. PubMed ID: 38056387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.